Getting a clear picture of the beating heart has always been a challenge. The artificial intelligence developer UltraSight hopes to make it much easier by giving clinicians a computer-guided helping hand.

Takeda is leaving the coop, handing the rights of two Finch eggs back to the microbiome-focused biotech.

Sometimes, finding out that an enzyme doesn’t work the way you thought it did means you have to go back to the drawing board. Then there are times when it turns out to be a fortuitous discovery that could pave the way for treatments for one of medicine’s most challenging conditions—in this case, sepsis. The dangerous inflammatory response most frequently arises from a bacterial infection entering the bloodstream and spreading throughout the body.

The Association of Clinical Research Organizations (ACRO) is stepping up its efforts to address the age-old problem of the lack of diversity in clinical trial populations. With its principles statement, the trade group has set out what its members will do to make clinical trials—and their own workforces—more diverse.

Just a few months after Fitbit roped in FDA clearance for an algorithm that could be embedded into its eponymous health-tracking wearables to detect atrial fibrillation, the technology is ready to hit the ground running.

Preparing an electroencephalogram test—designed to measure electrical activity in the brain—can be a time-consuming task. It typically requires clinicians to apply gel adhesive to about two dozen electrodes, then place them precisely across the scalp, one by one, before the test can begin.

Lewis Carroll’s White Rabbit may have been woefully behind schedule, but Silicon Valley’s Whiterabbit.ai is hoping to keep patients solidly on time for regular breast cancer screenings.

Researchers at MIT have developed a sensor, about the size and shape of a WiFi router, which they say can help track Parkinson’s patients’ breathing while they sleep. Tracking is completely contact-free, and the device alerts caregivers to any progression of the condition—and could also be used to diagnose Parkinson’s.

Anne-Virginie Eggimann has spread her wings, departing from bluebird bio and landing at biotech Tessera Therapeutics, where she will serve as chief regulatory officer.

In contrast to other up-and-coming robotic surgery systems, one newly cleared by the FDA acts less like an autonomous assistant and more like a surgeon’s extra pair of hands.